Urokinase and plasminogen activator-inhibitor (PAI-1) status in primary ovarian carcinomas and ovarian metastases compared to benign ovarian tumors as a function of histopathological parameters. - Hoffmann,G.; Pollow,K.; Weikel,W.; Strittmatter,H.J.; Bach,J.; Schaffrath,M.; Knapstein,P.; Melchert,F.; Pollow,B. (Clin Chem Lab Med, 1999)